The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal...

Area of Science:

• Oncology
• Microbiology
• Environmental Health

Background:

• Prostate cancer progression is linked to androgen signaling and environmental factors.
• The gut microbiome modulates host metabolism, immunity, and hormone activity, impacting cancer.
• Emerging evidence links the gut microbiota to prostate cancer risk and treatment outcomes.

Purpose of the Study:

• To review the current understanding of the gut-prostate axis.
• To examine the mechanisms connecting gut microbial activity to prostate cancer biology.
• To discuss potential microbiome-based therapeutic strategies for prostate cancer.

Main Methods:

• Literature review of studies on the gut microbiome and prostate cancer.
• Analysis of mechanistic links between microbial enzymes (e.g., β-glucuronidase) and androgen metabolism.
• Examination of microbial metabolites' roles in inflammation and tumorigenesis.
• Review of experimental interventions targeting the gut microbiota (diet, probiotics, FMT).

Main Results:

• Specific gut microbes influence androgen biosynthesis and metabolism via enzymes like β-glucuronidase.
• Microbial metabolites (SCFAs, bile acids, genotoxins) impact prostate cancer-related inflammation and signaling.
• Modulating the gut microbiota can affect tumor growth and response to therapies.
• A bidirectional crosstalk exists between the gut microbiota and prostate cancer.

Conclusions:

• The gut microbiome is a significant factor in prostate cancer development and progression.
• Microbiome-based strategies offer potential for novel approaches in prostate cancer prevention and treatment.
• Further research into the gut-prostate axis can inform personalized medicine for prostate cancer.